2025-11-06T18:40:04-06:00 2024-12-31 814234542 BPM LLP 10 ALMADEN BOULEVARD SUITE 1000 SAN JOSE CA 951132238 990 2024-01-01 264443340 MEDICINES360 MEDI 4159518700 49 STEVENSON STREET 1100 SAN FRANCISCO CA 94105 BRADLEY LUKE CFO/COO 4159518700 2025-11-04 1 1 TAMARA L MCINERNEY P00011797 4089616300 2025-11-04 2024 2025-03-06 01:10:19Z ANDREA OLARIU 49 STEVENSON STREET 1100 SAN FRANCISCO CA 94105 29233254 0 X HTTP://WWW.MEDICINES360.ORG X 2009 CA MEDICINES360 IS A NON-PROFIT WOMEN'S HEALTH ORGANIZATION THAT FOCUSES ON DEVELOPING NEW PRODUCTS AND ACCELERATING ACCESS TO INNOVATION FOR WOMEN. 7 6 33 0 78 0 854099 2914846 0 0 -6717 1691229 9159360 10152986 10006742 14759061 43735 6886 0 0 10608675 8537102 0 0 545651 8674087 7286992 19326497 15830980 -9319755 -1071919 51992405 51961979 5160104 3998733 46832301 47963246 MEDICINES360 IS A NON-PROFIT WOMEN'S HEALTH ORGANIZATION THAT FOCUSES ON DEVELOPING NEW PRODUCTS AND ACCELERATING ACCESS TO INNOVATION FOR WOMEN. 0 0 11331488 6886 206192 THE ORGANIZATION RECEIVED NDA APPROVAL FOR ITS IUD PRODUCT LILETTA IN 2015. LILETTA HAS BEEN DISTRIBUTED THROUGH MEDICINES360'S COMMERCIAL PARTNER SINCE APRIL 2015. IN ADDITION, THE ORGANIZATION CONTINUES DEVELOPING CERTAIN MEDICAL PRODUCTS RELATING TO WOMEN'S REPRODUCTIVE HEALTH AND WORKS TO EXPAND ACCESS TO ALL WOMEN IN NEED. 11331488 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 48 0 1 33 1 0 0 0 0 0 0 0 0 0 0 0 0 X 7 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X NATALIE OTTEN 4159518700 49 STEVENSON STREET SUITE 1100 SAN FRANCISCO CA 94105 ANDREA OLARIU CEO 40.00 0.00 X X 771904 0 331622 LISA DAVID BOD CHAIR 2.00 0.00 X 60000 0 0 KAREN DAWES DIRECTOR 2.00 0.00 X 40000 0 0 ANN BARBER DIRECTOR 2.00 0.00 X 40000 0 0 MIKE DORSEY DIRECTOR 2.00 0.00 X 40000 0 0 ELIZABETH GARNER DIRECTOR 2.00 0.00 X 40000 0 0 LESLIE BENET DIRECTOR (TO 6/2024) 2.00 0.00 X 20000 0 0 ERICA ROGERS DIRECTOR (FROM 6/2024 TO 12/2024) 2.00 0.00 X 30000 0 0 BRADLEY LUKE CHIEF FINANCIAL OFFICER 40.00 0.00 X 519704 0 148716 CYNTHIA HU GENERAL COUNSEL/BOD SEC (TO 6/2024) 37.81 2.19 X 499660 0 31125 ROBERT DECKMAN VP, PRODUCT DEVELOPMENT & SUSTAIN ENG 40.00 0.00 X 400501 0 141758 AUTUMN EHNOW EVP, CORPORATE AFFAIRS 40.00 0.00 X 423485 0 142989 MARK BUSCH SVP, QUALITY ASSURANCE & PRODUCT SAFETY 37.74 2.26 X 398963 0 107456 MARGOT FAHNESTOCK VP, STRATEGIC DEVELOPMENT 37.81 2.19 X 355845 0 33051 NATALIE OTTEN VP, FINANCE & ACCOUNTING 35.66 4.34 X 354739 0 117820 3994801 0 1054537 28 0 1 0 POBA MEDICAL INC 3001 W SHEMRELL BLVD FLAGSTAFF AZ 86005 CONSULTANT SERVICES 571684 POLYVATION BV KADIJK 7D 9747 AT GRONINGEN PO B GRONINGEN NL 9704 AA CONSULTANT SERVICES 285000 BAPNA CONSULTING CORPORATION 6 CUTLER COURT SUFFERN NY 10901 CONSULTANT SERVICES 195153 VEEVA SYSTEMS INC 4280 HACIENDA DR PLEASANTON CA 94588 CLOUD-BASED SOFTWARE 170936 BUCHLATER 425 MARKET STREET SUITE 2900 SAN FRANCISCO CA 94105 LEGAL SERVICES 166875 12 2914846 1801194 2914846 1452637 78 1452559 9946794 9946794 14468538 14229946 238592 238592 238592 162289 244247 -81958 -81958 CO-PROMOTIONAL REVENUE 900099 288000 288000 OTHER INCOME 900099 150 150 288150 14759061 206192 78 11637945 X 4307 4307 2579 2579 2217616 1517921 619087 80608 5167755 3537241 1442672 187842 160449 109825 44792 5832 606659 415248 169360 22051 384623 263268 107374 13981 392091 324786 67305 132467 132467 13275 13275 151251 151251 3625919 2934795 546003 145121 512948 512948 501881 343529 140109 18243 588674 402937 164339 21398 410904 281257 114711 14936 229857 203318 23482 3057 465694 318760 130007 16927 PAYROLL PROCESS FEE 67408 46140 18816 2452 DUES & FEES 45870 32525 3344 10001 UBIT AND EXCISE TAX 36494 0 36494 0 RECRUITING 36211 24786 10109 1316 76048 42043 32119 1886 15830980 11331488 3953841 545651 811209 639098 1202424 1336302 2473387 2920133 356789 141642 941546 780162 2514145 2143681 552980 370464 42851767 43484545 1000 1000 2801303 2288633 51992405 51961979 3347536 2753753 1812568 1244980 5160104 3998733 X 46041798 46399829 790503 1563417 46832301 47963246 51992405 51961979 -1071919 2202864 0 X 0 1 X 1 0 X UNIVERSITY OF CALIFORNIA DAVIS CA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 0 0 0 1 14691 0 0 14691 0 PART II-B, LINE 1: MEDICINES360'S POLICY POSITIONS HAVE BEEN ROOTED IN EVIDENCE WITH A FOCUS ON PROVIDING A CORPORATE RESPONSE TO PROTECT AND CONVEY OUR MISSION AS A NON-PROFIT PHARMACEUTICAL ORGANIZATION FOCUSED ON WOMEN'S HEALTH INNOVATION. WE HAVE ACTIVELY ENGAGED WITH FEDERAL AND STATE POLICY MAKERS TO ADVOCATE FOR POLICY CHANGE THAT WOULD IMPROVE THE ABILITY OF A NONPROFIT PHARMACEUTICAL ORGANIZATION TO COMPLETE MISSION WORK. WE HAVE ALSO WORKED TO CONVEY OUR POSITION ON 340B POLICIES, TITLE X AND LARC RELATED AND DRAFT LEGISLATION. WE HAVE ALSO ISSUED MEDIA STATEMENTS ON OUR PRIORITY ISSUES AND PUBLIC COMMENT TO THE RECORD FOR SENATE AND HOUSE HEARINGS ON THOSE TOPICS 231565 137977 93588 1877614 1655826 221788 404966 349878 55088 370464 DEFERRED LEASE LIABILITY 1244980 1244980 X PART X, LINE 2: AS OF DECEMBER 31, 2024 AND 2023, THE COMPANY HAD NO UNRECOGNIZED TAX BENEFITS. THE COMPANY DOES NOT EXPECT ANY MATERIAL CHANGES TO ITS UNRECOGNIZED TAX BENEFITS WITHIN THE NEXT TWELVE MONTHS. AS A RESULT, THE COMPANY DID NOT RECOGNIZE INTEREST AND PENALTIES RELATED TO UNCERTAIN TAX POSITIONS AS A COMPONENT OF INCOME TAX EXPENSE. 0 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES OUTSOURCED SERVICES, CONSULTING, REGULATORY AFFAIRS 155754 EUROPE 0 0 PROGRAM SERVICES INVENTORY RELATED TO AVIBELA SALES, OUTSOURCED SERVICES 377069 SOUTH ASIA 0 0 PROGRAM SERVICES OUTSOURCED SERVICES 113 SUB-SAHARAN AFRICA 0 0 GRANTS 2579 EUROPE 0 0 PROGRAM REVENUE - $17,100 SUB-SAHARAN AFRICA 0 0 PROGRAM REVENUE - $89,064 CENTRAL AMERICA 0 0 PROGRAM REVENUE - $56,125 0 0 0 0 0 0 535515 0 535515 0 0 0 0 0 0 1 X X X X X 1 0 0 0 0 0 0 1 0 ANDREA OLARIU CEO 563958 0 205249 0 2697 0 262938 0 68684 0 1103526 0 205249 0 BRADLEY LUKE CHIEF FINANCIAL OFFICER 390335 0 124392 0 4977 0 135877 0 12839 0 668420 0 124392 0 AUTUMN EHNOW EVP, CORPORATE AFFAIRS 310976 0 110724 0 1785 0 96085 0 46904 0 566474 0 110724 0 ROBERT DECKMAN VP, PRODUCT DEVELOPMENT & SUSTAIN EN 311161 0 84363 0 4977 0 94682 0 47076 0 542259 0 84363 0 CYNTHIA HU GENERAL COUNSEL/BOD SEC (TO 6/2024) 189847 0 46305 0 263508 0 7315 0 23810 0 530785 0 46305 0 MARK BUSCH SVP, QUALITY ASSURANCE & PRODUCT SAF 286209 0 103535 0 9219 0 85078 0 22378 0 506419 0 103535 0 NATALIE OTTEN VP, FINANCE & ACCOUNTING 271137 0 81832 0 1770 0 84340 0 33480 0 472559 0 81832 0 MARGOT FAHNESTOCK VP, STRATEGIC DEVELOPMENT 279488 0 73710 0 2647 0 10350 0 22701 0 388896 0 73710 0 PART I, LINE 4A SEVERANCE PAYMENTS DURING 2024 WERE AS FOLLOWS: CYNTHIA HU $260,842 PART I, LINE 7 EMPLOYEES OF MEDICINES360 RECEIVED DISCRETIONARY BONUSES THAT WERE APPROVED BY THE BOARD OF DIRECTORS AND DETERMINED BY THE FOLLOWING: 1. ELIGIBILITY 2. ACHIEVEMENT OF THE MEDICINES360 CONSOLIDATED MISSION GOALS 3. ACHIEVEMENT OF THE EMPLOYEE'S INDIVIDUAL GOALS 4. EMPLOYEE'S TARGET BONUS AS A PERCENTAGE OF SALARY AND ALLOCATION OF BONUS BETWEEN MEDICINES360 CONSOLIDATED MISSION GOALS AND INDIVIDUAL GOALS FOR THEIR LEVEL. 5. MANAGEMENT AND THE BOARD OF DIRECTORS' DISCRETION X 1 1801194 FMV 0 0 0 PART I, COLUMN (B): AMOUNT REPRESENTS THE NUMBER OF CONTRIBUTIONS FORM 990, PART VI, SECTION B, LINE 11B BEFORE FILING, THE TAX RETURN IS PROVIDED TO THE BOARD AUDIT COMMITTEE FOR THEIR REVIEW AND APPROVAL, AND THE FULL BOARD FOR THEIR REVIEW. FORM 990, PART VI, SECTION B, LINE 12C OFFICERS/DIRECTORS ARE REQUIRED TO DISCLOSE OR UPDATE ANNUALLY INTERESTS THAT COULD GIVE RISE TO CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE CEO COMPENSATION IS SET ON THE BASIS OF SALARY RANGES FOR COMPARABLY SIZED COMPANIES IN THE RADFORD GLOBAL LIFE SCIENCES SURVEY DATA AND COMPARABLE NON-PROFITS. THE COMPENSATION OF OFFICERS AND KEY EMPLOYEES ARE BENCH-MARKED AGAINST THE RADFORD GLOBAL LIFE SCIENCES SURVEY DATA AND COMPARABLE NON-PROFITS. THE BOARD OF DIRECTORS REVIEWS AND APPROVES THE DATA AND COMPENSATION FOR THE CEO. THE COMPENSATION OF OFFICERS IS REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE, WHICH IS COMPRISED OF INDEPENDENT BOARD MEMBERS. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G CONSULTANTS: PROGRAM SERVICE EXPENSES 1,155,669. MANAGEMENT AND GENERAL EXPENSES 162,315. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,317,984. OUTSOURCED SERVICES: PROGRAM SERVICE EXPENSES 1,345,604. MANAGEMENT AND GENERAL EXPENSES 383,688. FUNDRAISING EXPENSES 145,121. TOTAL EXPENSES 1,874,413. FDA FEES: PROGRAM SERVICE EXPENSES 433,522. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 433,522. IMPACT RH360 LLC 49 STEVENSON ST SUITE 1150 SAN FRANCISCO CA 94105 MEDICAL PRODUCT DISTRIBUTION CA 162439 244362 MEDICINES360 CURAE PHARMA360 INC 49 STEVENSON ST SUITE 1100 SAN FRANCISCO CA 94105 460978720 MEDICAL PRODUCT SALES & DISTRIBUTION CA MEDICINES360 C 20849 337777 1.00000 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 CURAE PHARMA360 INC N 6748 ACTUAL CURAE PHARMA360 INC O 17438 ACTUAL CURAE PHARMA360 INC Q 137188 ACTUAL